These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25407133)

  • 1. An update on the use of botulinum toxin therapy in Parkinson's disease.
    Mills R; Bahroo L; Pagan F
    Curr Neurol Neurosci Rep; 2015 Jan; 15(1):511. PubMed ID: 25407133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-oriented approach to botulinum toxin use.
    Jankovic J
    Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Therapy for Parkinson's Disease.
    Wagle Shukla A; Malaty IA
    Semin Neurol; 2017 Apr; 37(2):193-204. PubMed ID: 28511260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.
    Jost WH
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33503872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
    Sheffield JK; Jankovic J
    Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in the management of parkinsonian disorders.
    Grippe T; Chen R
    Toxicon; 2023 Aug; 232():107209. PubMed ID: 37429465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of botulinum toxin in Parkinson's disease.
    Jocson A; Lew M
    Parkinsonism Relat Disord; 2019 Feb; 59():57-64. PubMed ID: 30579818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Digestive disorders in Parkinson's disease: dysphagia and sialorrhea].
    González-Fernández J; Prieto-Albin R; Velasco-Palacios L; Jorge-Roldán S; Cubo-Delgado E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S51-4. PubMed ID: 20205142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on new and unique uses of botulinum toxin in movement disorders.
    Jankovic J
    Toxicon; 2018 Jun; 147():84-88. PubMed ID: 28888928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin treatment in parkinsonism.
    Anandan C; Jankovic J
    J Neurol Sci; 2024 Jan; 456():122810. PubMed ID: 38056063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin treatment of secretory disorders.
    Naumann M; Jost W
    Mov Disord; 2004 Mar; 19 Suppl 8():S137-41. PubMed ID: 15027066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin in parkinsonism: The when, how, and which for botulinum toxin injections.
    Cardoso F
    Toxicon; 2018 Jun; 147():107-110. PubMed ID: 28837826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.
    Mitchell SD; Sidiropoulos C
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin: clinical use.
    Truong DD; Jost WH
    Parkinsonism Relat Disord; 2006 Sep; 12(6):331-55. PubMed ID: 16870487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tremor-predominant Parkinson's disease. Approaches to treatment.
    Marjama-Lyons J; Koller W
    Drugs Aging; 2000 Apr; 16(4):273-8. PubMed ID: 10874522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxins in the treatment of primary focal dystonias.
    Truong D
    J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin in movement disorders.
    Tater P; Pandey S
    Neurol India; 2018; 66(Supplement):S79-S89. PubMed ID: 29503330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum Toxin for the Management of Parkinson's Disease: A Systematic Review.
    Slouha E; Ibrahim F; Esposito S; Mursuli O; Rezazadah A; Clunes LA; Kollias TF
    Cureus; 2024 Jan; 16(1):e53309. PubMed ID: 38435899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxin in Movement Disorders: An Update.
    Anandan C; Jankovic J
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33430071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.